Browsing by Yonsei Author : Kim, Joo Hang

Name:
김주항 [Kim, Joo Hang]
Department :
College of Medicine - Dept. of Internal Medicine
Y-HRN :
(Yonsei Health Research Network)

Keyword Cloud

Researcher Network

This table browses all dspace content
Issue DateTitleYonsei Author(s)Type
2017Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.김주항, 김혜련, 심효섭, 임선민, 조병철article
2017A randomized; phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) (vol 8; pg 15943; 2017) 김주항, 김혜련, 정인경, 조병철article
2016Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer. 김영진, 김주항, 문용화, 서영주, 심효섭, 이혜정, 임동진, 조응혁, 최병욱, 허진, 홍유진article
2016Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma고윤우, 김주항, 김혜련, 이창걸, 조병철, 최은창article
2016Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer 금기창, 김세헌, 김주항, 김준원, 이창걸article
2016EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines 김민환, 김주항, 김혜련, 문용화, 백순명, 임선민, 조병철article
2016Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells김주항, 송재진, 최혜진article
2016Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy김주항, 김혜련, 박형순, 이민구, 조병철, 조응혁article
2015Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck고윤우, 권형주, 김주항, 김한상, 김혜련, 백순명, 이민구, 이지현, 정인경, 조병철, 최은창article
2015Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells김주항, 송재진, 최혜진article
2015Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication 구자승, 김민환, 김승일, 김주항, 박병우, 박세호, 박형석, 손주혁, 정준article
2015The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer김대준, 김세규, 김은영, 김주항, 김혜련, 김효송, 박지수, 심효섭, 이창영, 장준, 정인경, 정지예, 조병철article
2015An open label, multicenter, phase II study of dovitinib in advanced thyroid cancer강상욱, 강찬우, 김주항, 김혜련, 남기현, 임선민, 임재윤, 정웅윤, 조병철article
2015LAMC2 enhances the metastatic potential of lung adenocarcinoma김주항, 문용화, 심효섭, 정현철article
2015Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma 강찬우, 강한나, 김대준, 김주항, 김혜련, 김환, 문용화, 백순명, 윤미란, 임선민, 장강원, 조병철, 표경호article
2015Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma 김대준, 김주항, 김현기, 김혜련, 김효송, 문용화, 박준철, 백순명, 신성관, 이상길, 이용찬, 이창걸, 정현수, 조병철, 표경호, 허진article
2015Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest김주항, 송재진article
2015Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma. 김대준, 김주항, 김현기, 김혜련, 김효송, 박준철, 신성관, 이상길, 이용찬, 이창걸, 정다현, 조병철, 허진article
2014Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers 김대준, 김세규, 김은영, 김주항, 김한상, 김혜련, 배미경, 심효섭, 이민구, 이지현, 이진구, 이창영, 장준, 정경영, 정지예, 조병철article
2014Clinical Outcome According to the Level of Preexisting Epidermal Growth Factor Receptor T790M Mutation in Patients With Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations김주항article
2014Establishment of a mouse melanoma model system for the efficient infection and replication of human adenovirus type 5-based oncolytic virus김주항, 송재진article
2014Tumor MET expression profile predicts the outcome of non-small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitors김주항, 박희진, 조병철article
2014Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma김대준, 김세규, 김주항, 김혜련, 심효섭, 임선민, 장준, 조병철article
2014Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations강대용, 김민환, 김은영, 김주항, 김혜련, 배미경, 이재석, 이창영, 조병철article
2014Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma김대준, 김민환, 김은영, 김주항, 김현정, 김혜련, 박지수, 배미경, 심효섭, 이진구, 이창영, 임선민, 정경영, 정지예, 조병철article
2014A prospective phase II trial of s-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer김대준, 김주항, 김충배, 김형일, 김혜련, 박준철, 배미경, 신성관, 이상길, 이용찬, 이진구, 이창걸, 이창영, 이혁, 조병철, 차지혜, 허진article
2014Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.김주항article
2013A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes강상욱, 김주항, 김현정, 남기현, 박정수, 윤미진, 임선민, 정웅윤, 조병철article
2013Prolonged clinical benefit from the maintenance hormone therapy in patients with metastatic breast cancer김승일, 김주항, 박병우, 박세호, 손주혁, 이수현, 임승택, 최혜진, 한정우article
2013S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial 구자승, 김민정, 김승일, 김은경, 김주항, 박병우, 박세호, 손주혁, 이수현, 정현철article
2013Glycolysis Inhibition Sensitizes Non–Small Cell Lung Cancer with T790M Mutation to Irreversible EGFR Inhibitors via Translational Suppression of Mcl-1 by AMPK Activation김선미, 김주항, 조병철article
2013Better Outcome of XELOX Chemotherapy in Patients with Advanced Intestinal-Type Adenocarcinoma of the Ampulla of Vater 김주항, 김한상, 김현기, 신상준, 최혜진article
2013Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer 강창무, 김주항, 송시영, 윤미진, 이우정, 이재훈, 이종두, 조응혁, 최혜진article
2013Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung 강영애, 김대준, 김세규, 김주항, 라선영, 박형순, 이지현, 이철호, 장준, 정민규, 조병철article
2013Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors 김주항, 김한상, 김효송, 노재경, 라선영, 손주혁, 신상준, 안중배, 이수현, 정현철, 조병철, 최혜진article
2013The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma 김주항, 김혜련, 배미경, 심효섭, 조병철article
2013Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer김건민, 김다래, 김세규, 김세현, 김영삼, 김은영, 김주항, 김한상, 김혜련, 박무석, 박지수, 이준호, 임선민, 임승택, 장준, 정지예, 조병철article
2013The Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma 김주항, 김혜련, 남기창, 라선영, 안정련, 이진구, 조병철, 홍윤경article
2013Crosstalk from survival to necrotic death coexists in DU-145 cells by curcumin treatment: Inhibition of apoptosis by caspase degradation.김주항, 송재진article
2013Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer강대용, 김대준, 김세훈, 김주항, 김혜련, 라선영, 배미경, 심효섭, 이지현, 이진구, 이창영, 임선민, 정경영, 조병철article
2013The effectiveness of the oncolytic activity induced by Ad5/F35 adenoviral vector is dependent on the cumulative cellular conditions of survival and autophagy김주항, 송재진article
2013c-Cbl shRNA-expressing adenovirus sensitizes TRAIL-induced apoptosis in prostate cancer DU-145 through increases of DR4/5김주항, 송재진article
2013Transforming growth factor-β gene silencing using adenovirus expressing TGF-β1 or TGF-β2 shRNA김주항, 송재진article
2013TRAIL/MEKK4/p38/HSP27/Akt survival network is biphasically modulated by the Src/CIN85/c-Cbl complex김주항, 송재진article
2013A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)김선미, 김세현, 김주항, 김혜련, 심효섭, 장현, 조병철, 조재호, 홍윤경article
2012Treatment outcome of patients with anaplastic thyroid cancer: a single center experience 강상욱, 금기창, 김주항, 남기현, 박정수, 신상준, 임선민, 정웅윤, 조병철, 조재용article
2012Overexpression of class III beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy 구자승, 김승일, 김주항, 라선영, 문용화, 박병우, 박세호, 손주혁, 이수현, 정민규, 정현철, 홍수정article
2012Activation of IL-6R/JAK1/STAT3 signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation권오준, 김선미, 김주항, 이지현, 조병철, 홍윤경article
2012Efficacy and toxicity of belotecan for relapsed or refractory small cell lung cancer patients강영애, 김건민, 김선미, 김세규, 김영삼, 김주항, 임승택, 조병철article
2012High EGFR gene copy number and skin rash as predictive markers for EGFR tyrosine kinase inhibitors in patients with advanced squamous cell lung carcinoma. 김세훈, 김주항, 박무석, 심효섭, 조병철article

Browse